Immunogenicity and predictive factors of hepatitis B vaccination with Fendrix<sup>®</sup> in chronic kidney disease patients. [PDF]
Hernán-García C+6 more
europepmc +1 more source
Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study. [PDF]
Zhuang C+19 more
europepmc +1 more source
Association of Vaccination in Pregnancy With Newborn Hepatitis B Vaccine Receipt. [PDF]
Young Graf Z+5 more
europepmc +1 more source
Global Burden of Vaccine-Associated Cerebrovascular Venous Sinus Thrombosis, 1968-2024: A Critical Analysis From the WHO Global Pharmacovigilance Database. [PDF]
Cho J+7 more
europepmc +1 more source
Infection prevention in the immunocompromised traveler due to conditions other than transplantation: a review. [PDF]
Sassine J+4 more
europepmc +1 more source
Cross-sectional study of vaccine coverage among children aged 1 to 24 months in Opuwo District, Kunene region, Namibia. [PDF]
Akwenye LSM+5 more
europepmc +1 more source
Hepatitis B vaccination coverage and associated factors among children living in northwest Ethiopia city administrations: A community-based study. [PDF]
Geta M, Hailu A, Woldeamanuel Y.
europepmc +1 more source
Related searches:
Immunization is the most effective way to prevent transmission of HBV and, hence, the development of acute or chronic hepatitis B. The national strategy to eliminate transmission of the virus in the United States includes vaccination of all newborn infants, children, adolescents, and high-risk adults.
A. Yu, R. Cheung, E. Keeffe
semanticscholar +6 more sources